Stories about: Ofer Levy

Radiation sickness: A two-drug combination could block radiation’s double hit

A two-drug combination could help raise the odds of surviving toxic doses of radiation released through accidents like those at Chernobyl (above) or Fukushima, or by a nuclear or radiological weapon. (Kamil Porembinski/Flickr)

Radiation can have its benefits – look at radiation therapy for cancer, or imaging technologies like X-rays and CT scans that use radiation to peer within our bodies. But high doses, from malfunctioning medical equipment, accidents like those at Chernobyl or Fukushima, or nuclear or radiological weapons, can be toxic or even lethal.

Right now, there are treatments in development that could raise the odds of surviving exposure to toxic doses of radiation, but only if given within a few minutes or hours of exposure. Ofer Levy of Children’s Division of Infectious Diseases and his collaborator Eva Guinan at Dana-Farber Cancer Institute have hit upon a new-two drug combination that markedly increased survival in mice when given as late as 24 hours after exposure.

Read Full Story | Leave a Comment

A distant star: a single vaccine at birth

Ofer Levy is nothing if not passionate. Talking about his new project, he starts taking notes on my pad for me, to make sure I catch every detail. When Levy was getting his MD/PhD at NYU, one of his mentors told him, “In pursuing your life’s passion as a researcher, you should set your sights on a distant star.”

Read Full Story | Leave a Comment